Dr. Michael D. Ehlers, also known as Mike, M.D., Ph.D., has been an Executive Vice President and Head of Research & Development at Biogen Inc. since May 2016. Dr. Ehlers served as Group Senior Vice President, Head of BioTherapeutics Research & Development and Site Head for Cambridge & Boston, Massachusetts locations at Pfizer Inc. from May 2015 to April 2016. He served as the Chief Scientific Officer for Neuroscience and Pain Research Unit at Pfizer Inc. until April 2016. Dr. Ehlers was responsible for a network of collaborations with major academic and government institutions. He served as the Director of neuroproteomics laboratory at Duke University. Prior to joining Pfizer in 2010, Dr. Ehlers was the George Barth Geller Professor of Neurobiology and an Investigator of the Howard Hughes Medical Institute at Duke University Medical Center, where he pioneered studies on neuronal organelles and the trafficking of neurotransmitter receptors. He is a recognized leader in applying the highest quality science to critical health issues in neurodegenerative and rare diseases. He holds M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine and has authored more than 100 scientific papers. He also holds BS in Chemistry from California Institute of Technology.

Neurobiology